首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >MicroRNAs/TP53 feedback circuitry in glioblastoma multiforme
【24h】

MicroRNAs/TP53 feedback circuitry in glioblastoma multiforme

机译:胶质母细胞瘤中的MicroRNA / TP53反馈电路

获取原文
获取原文并翻译 | 示例
       

摘要

MicroRNAs (miRNAs) are increasingly implicated in regulating cancer initiation and progression. In this study, two miRNAs, miR-25 and -32, are identified as p53-repressed miRNAs by p53-dependent negative regulation of their transcriptional regulators, E2F1 and MYC. However, miR-25 and -32 result in p53 accumulation by directly targeting Mdm2 and TSC1, which are negative regulators of p53 and the mTOR (mammalian target of rapamycin) pathway, respectively, leading to inhibition of cellular proliferation through cell cycle arrest. Thus, there is a recurrent autoregulatory circuit involving expression of p53, E2F1, and MYC to regulate the expression of miR-25 and -32, which are miRNAs that, in turn, control p53 accumulation. Significantly, overexpression of transfected miR-25 and -32 in glioblastoma multiforme cells inhibited growth of the glioblastoma multiforme cells in mouse brain in vivo. The results define miR-25 and -32 as positive regulators of p53, underscoring their role in tumorigenesis in glioblastoma.
机译:MicroRNA(miRNA)越来越多地参与调节癌症的发生和发展。在这项研究中,两个miRNA miR-25和-32通过其转录调节因子E2F1和MYC的p53依赖性负调控被鉴定为p53抑制的miRNA。但是,miR-25和-32通过直接靶向Mdm2和TSC1导致p53积累,Mdm2和TSC1分别是p53和mTOR(雷帕霉素的哺乳动物靶标)途径的负调节剂,从而导致通过细胞周期停滞抑制细胞增殖。因此,存在涉及p53,E2F1和MYC的表达的复发性自动调节电路,以调节miR-25和-32的表达,而miR-25和-32是又控制p53积累的miRNA。明显地,在胶质母细胞瘤多形细胞中转染的miR-25和-32的过表达在体内抑制了胶质母细胞瘤多形细胞的生长。结果将miR-25和-32定义为p53的正调节剂,强调了它们在胶质母细胞瘤的肿瘤发生中的作用。

著录项

  • 来源
  • 作者单位

    Department of Molecular Virology, Immunology, and Medical Genetics, Comprehensive Cancer Center, Ohio State University, Columbus, OH 43210;

    Dardinger Laboratory for Neuro-Oncology and Neurosciences, Department of Neurological Surgery, Comprehensive Cancer Center, Ohio State University Medical Center, Columbus, OH 43220;

    Department of Molecular Virology, Immunology, and Medical Genetics, Comprehensive Cancer Center, Ohio State University, Columbus, OH 43210;

    Department of Molecular Virology, Immunology, and Medical Genetics, Comprehensive Cancer Center, Ohio State University, Columbus, OH 43210;

    Department of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104;

    Department of Molecular Virology, Immunology, and Medical Genetics, Comprehensive Cancer Center, Ohio State University, Columbus, OH 43210;

    Department of Molecular Virology, Immunology, and Medical Genetics, Comprehensive Cancer Center, Ohio State University, Columbus, OH 43210;

    Unita Operativa Complessa Anatomia Patologica, Azienda-Complesso Ospedaliero San Filippo Neri, 00135 Rome, Italy;

    Department of Molecular Virology, Immunology, and Medical Genetics, Comprehensive Cancer Center, Ohio State University, Columbus, OH 43210;

    Dardinger Laboratory for Neuro-Oncology and Neurosciences, Department of Neurological Surgery, Comprehensive Cancer Center, Ohio State University Medical Center, Columbus, OH 43220;

    Department of Molecular Virology, Immunology, and Medical Genetics, Comprehensive Cancer Center, Ohio State University, Columbus, OH 43210, The Lautenberg Center for General and Tumor Immunology, Department of Immunology and Cancer Research, Institute for Medical Research Israel-Canada, Hebrew University-Hadassah Medical School, Jerusalem 91120, Israel;

    Division of Hematology, Department of Internal Medicine, College of Medicine, Ohio State University, Columbus, OH 43210;

    Department of Molecular Virology, Immunology, and Medical Genetics, Comprehensive Cancer Center, Ohio State University, Columbus, OH 43210;

  • 收录信息 美国《科学引文索引》(SCI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 00:40:18

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号